LIVN News and Press, LivaNova PLC From 04/29/21

After a post-earnings rally yesterday, one healthcare equipment company reached up and touched $90/share, for just a minute - and "stocks that go to $90 tend to go to $100," or so the aphorism goes, Baird notes. But $100 is its new price target for LivaNova (LIVN), which closed Wednesday up 4...

Image source: The Motley Fool. LivaNova PLC (NASDAQ: LIVN) Q1 2021 Earnings Call Apr 28, 2021 , 7:00 a.m. ET Operator Continue reading For further details see: LivaNova PLC (LIVN) Q1 2021 Earnings Call Transcript

LivaNova PLC (LIVN): Q1 Non-GAAP EPS of $0.35 beats by $0.20; GAAP EPS of -$0.61 misses by $0.40.Revenue of $247.6M (+2.1% Y/Y) beats by $15.3M.Press Release For further details see: LivaNova PLC EPS beats by $0.20, beats on revenue

LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended March 31, 2021. For the first quarter of 2021, worldwide sales from continuing operations were $247.6 million, an increase of 2.1 percent on a report...

Medical technology company LivaNova (LIVN) and Alphabet (GOOG) subsidiary Verily announces that the first patient has been enrolled in their collaborative UNCOVER study.UNCOVER is a sub-study that deploys technology-enabled research tools from Verily to evaluate the real-world effectiven...

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, and Verily, a subsidiary of Alphabet focused on life sciences and healthcare, today announced that the first patient has been enrolled in their collaborative UNCOVER study or “The RECOVER ...

Shares of LivaNova PLC (NASDAQ:LIVN) traded at a new 52-week high today of $85.00. This new high was reached on below average trading volume as 115,000 shares traded hands, while the average 30-day volume is approximately 378,000 shares. LivaNova PLC (NASDAQ:LIVN) defies analysts with a ...

The following slide deck was published by LivaNova PLC in conjunction with this event. For further details see: LivaNova (LIVN) Cardiopulmonary Technology Presentation - Slideshow

LivaNova (LIVN) has received FDA 510(k) clearance for B-Capta, the new blood-gas monitoring system integrated into S5 heart-lung machine ((HLM)).The system is designed to easily and accurately monitor arterial and venous blood gas parameters even during long and complex pediatric and adu...

Intuitive, optical-based technology system now available around the world LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for B-Capta ® , the...